The latter view was appreciated by Bonifacius et al., who showed that COVID-19 patients with pre-existing anti-human coronavirus CD4+ and CD8+ T cells with cross-reactivity of endemic coronaviruses manifested higher frequency of SARS-CoV-2 S protein-specific T cells (Bonifacius et al., 2021). The gene discussed is CD4; the disease is COVID-19.